As we have mentioned previously, procaine hcl (GH3 Health Supplements) acts on many parts of the body. Clinical observations lend credence to the findings that procaine GH3 affects almost all those organs, glands, and functions that are particularly deficient in old age. It is important to bear in mind that these conditions are of chronic nature and require long-term treatment. Many of the failures with certain applications of the procaine therapy may stem from the fact that the treatment was not applied for a sufficiently extended period of time.”

The data in the table below cover a significantly large number of patients who were treated at the Parhon Institute who were treated during the years from 1952 through 1958, for a variety of diseases. Again, the statistics on improvement are much more convincing than those showing a lower mortality rate as compared to patients not treated with Procaine.

What diseases yield best to the procaine therapy, quite apart from the general improvement noticed in the patients? The statistics in this table indicate that diseases affecting the skin and hair, as well as a wide range of ailments with the central nervous system are most responsive. Among the former we find eczemas of differente etiology, alopecia, herpes zoster (shingles), psoriasis, vitiligo, itchthyosis and sclerderma, to name but few where some experiences gained. Among the latter gratifying results have been achieved in post-apoplectic situations, paralytic states, neuralgia and neuritis, Parkinsonism ( Parkinson’s ), Burger disease and multiple sclerosis. The application of procaine therapy ia also fruitfull in degenerative joint and bone diseases, such as arthritis, and different arthroses, osteoporosis, and Bechtere’s disease.

The table below illustrates the Pharon Institutes clinical and practical long term observations of a total of 875 patients with chronic nervous system, Locomotor, Cardiovascular system disorders, Skin and Hair problems and Gastric ulcers. As we can see, of the patients treated with procaine therapy, over 89% showed significant improvement, 8.2% were unchanged and 8.2 deaths were recorded or 2.7% motality rate during the seven year institute observations.

In should be noted that of the 495 Patients who were not treated with procaine, there were 54 deaths or 10.3% motality rate, significantly higher than the patients treated with the procaine therapy.